MCL1 and neoplasm: We found that SC‐60 treatment showed reduced tumor weight and suppressed tumor growth (Figs 4B and S6), increased SHP‐1 activity (Fig. 4C), and decreased p‐STAT3 and Mcl‐1 expressions in xenografted tumors (Figs 4D and S6).